Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

790 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
Velier M, Granata A, Bramanti S, Calmels B, Furst S, Legrand F, Harbi S, Faucher C, Devillier R, Blaise D, Mfarrej B, Lemarie C, Chabannon C. Velier M, et al. Among authors: granata a. Transfusion. 2019 Nov;59(11):3442-3447. doi: 10.1111/trf.15545. Epub 2019 Oct 18. Transfusion. 2019. PMID: 31625183
An intra-patient comparison of blood cell separators Spectra and Optia in patients and donors undergoing blood mononuclear cell collections at a single institution for subsequent autologous or allogeneic hematopoietic cell transplantation reveals comparable collection efficiencies.
Drezet A, Granata A, Lemarie C, Calmels B, Chabannon C. Drezet A, et al. Among authors: granata a. Bone Marrow Transplant. 2016 Jul;51(7):1007-9. doi: 10.1038/bmt.2016.41. Epub 2016 Mar 7. Bone Marrow Transplant. 2016. PMID: 26950377 No abstract available.
Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimen.
Collignon A, Calmels B, Harbi S, Fürst S, Granata A, Faucher C, Lemarie C, Weiller PJ, Chabannon C, Blaise D, Devillier R. Collignon A, et al. Among authors: granata a. Am J Hematol. 2017 Apr;92(4):E57-E59. doi: 10.1002/ajh.24661. Epub 2017 Feb 24. Am J Hematol. 2017. PMID: 28133837 Free article. No abstract available.
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Devillier R, Legrand F, Rey J, Castagna L, Fürst S, Granata A, Charbonnier A, Harbi S, d'Incan E, Pagliardini T, Faucher C, Lemarie C, Saillard C, Calmels B, Mohty B, Maisano V, Weiller PJ, Chabannon C, Vey N, Blaise D. Devillier R, et al. Among authors: granata a. Biol Blood Marrow Transplant. 2018 Jul;24(7):1449-1454. doi: 10.1016/j.bbmt.2018.02.002. Epub 2018 Feb 12. Biol Blood Marrow Transplant. 2018. PMID: 29448057 Free article.
Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF.
Garciaz S, Sfumato P, Granata A, Imbert AM, Fournel C, Calmels B, Lemarie C, Chiaroni J, Blaise D, Boher JM, Picard C, Chabannon C, di Cristofaro J. Garciaz S, et al. Among authors: granata a. PLoS One. 2020 Mar 5;15(3):e0228878. doi: 10.1371/journal.pone.0228878. eCollection 2020. PLoS One. 2020. PMID: 32134938 Free PMC article.
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Dachy F, Furst S, Calmels B, Pagliardini T, Harbi S, Bouchacourt B, Calleja A, Lemarie C, Collignon A, Morel G, Legrand F, Bekrieva E, Granata A, Weiller PJ, Chabannon C, Schiano JM, Vey N, Blaise D, Devillier R. Dachy F, et al. Among authors: granata a. Bone Marrow Transplant. 2023 Nov;58(11):1179-1181. doi: 10.1038/s41409-023-02033-0. Epub 2023 Aug 9. Bone Marrow Transplant. 2023. PMID: 37558780 No abstract available.
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Pagliardini T, Castagna L, Harbi S, Porta MD, Rey J, Fürst S, Bramanti S, Saillard C, Legrand F, Maisano V, Faucher C, Granata A, Hospital MA, Lining W, Weiller PJ, Calmels B, Charbonnier A, Lemarie C, Chabannon C, Vey N, Mokart D, Blaise D, Devillier R. Pagliardini T, et al. Among authors: granata a. Biol Blood Marrow Transplant. 2019 Sep;25(9):1803-1809. doi: 10.1016/j.bbmt.2019.05.014. Epub 2019 May 22. Biol Blood Marrow Transplant. 2019. PMID: 31128325 Free article. Clinical Trial.
Low incidence of chronic GVHD after HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patients.
Devillier R, Granata A, Fürst S, Harbi S, Faucher C, Weiller PJ, Chabannon C, Castagna L, Blaise D. Devillier R, et al. Among authors: granata a. Br J Haematol. 2017 Jan;176(1):132-135. doi: 10.1111/bjh.13923. Epub 2016 Apr 12. Br J Haematol. 2017. PMID: 27073182 Free article. No abstract available.
790 results